ストックスクリーナーアプリを入手
6.86
4.10%
0.27
前日終値:
$6.59
開ける：
$6.71
24時間の取引高:
94,743
Relative Volume:
1.68
時価総額：
$114.73M
収益：
-
当期純損益:
$-14.88M
株価収益率:
-7.00
EPS:
-0.98
ネットキャッシュフロー:
$-10.29M
1週間 パフォーマンス:
+11.54%
1か月 パフォーマンス:
+20.56%
6か月 パフォーマンス:
+7.02%
1年 パフォーマンス:
+10.29%
1日の値動き範囲:
$6.49
$6.89
1週間の範囲:
$5.86
$6.89
52週間の値動き範囲:
$4.65
$10.24
Coya Therapeutics Inc Stock (COYA) Company Profile
名前
Coya Therapeutics Inc
セクター
電話
650.739.3939
住所
12645 MEMORIAL DR., SUITE F1 #305, HOUSTON
COYA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
COYA
Coya Therapeutics Inc
|
6.86 | 100.52M | 0 | -14.88M | -10.29M | -0.98 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Coya Therapeutics Inc Stock (COYA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-09 | 開始されました | Lake Street | Buy |
| 2024-12-04 | 開始されました | D. Boral Capital | Buy |
Coya Therapeutics Inc (COYA) 最新ニュース
How volatile is Coya Therapeutics Inc. stockPortfolio Growth Summary & Weekly High Conviction Ideas - newsyoung.net
Why Coya Therapeutics Inc. stock attracts strong analyst attentionRate Hike & Daily Technical Stock Forecast Reports - 선데이타임즈
Published on: 2025-08-16 02:30:48 - newsyoung.net
Regulatory Risk and Reward: Navigating FDA Delays in the ALS Therapeutics Landscape - AInvest
Coya Therapeutics reports Q2 EPS (36c), consensus (43c) - MSN
Coya Therapeutics 2025 Q2 Earnings Sharp Loss Widens, Revenue Collapses - AInvest
Coya Therapeutics Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Coya Therapeutics’ (COYA) Buy Rating Reaffirmed at D. Boral Capital - Defense World
Is Coya Therapeutics Inc. stock ready for a breakoutPortfolio Update Summary & Free Fast Gain Swing Trade Alerts - Newser
Coya Therapeutics, Inc. (COYA) Reports Q2 Loss, Lags Revenue Estimates - MSN
Coya Therapeutics shares rise 2.46% after-hours after announcing participation in H.C. Wainwright 3rd Annual BioConnect Conference. - AInvest
Coya Therapeutics Inc. recovery potential after sell offStock Surge & Community Consensus Stock Picks - Newser
Coya Therapeutics Reports Second Quarter Financial Results and Provides a Corporate Update - BioSpace
Coya Therapeutics Reports Increased Losses Amid Development Focus - TipRanks
Coya Therapeutics' $75M Mixed Shelf: Fueling Neuroinflammation Breakthroughs in ALS, Alzheimer's, and Dementia - AInvest
Coya Therapeutics Files $75 Million Mixed Shelf and Reports Q2 Earnings - AInvest
Coya Therapeutics Files $75 Million Mixed Shelf - MarketScreener
Coya Therapeutics Highlights Q2 2025 Financial Results - TipRanks
Coya Therapeutics, Inc. SEC 10-Q Report - TradingView
Is Coya Therapeutics Inc. trending in predictive chart modelsDay Trading Setup and Momentum Analysis - Newser
How Resilient Is Coya Therapeutics Inc. Stock During Economic DownturnsValue Holding Return Summary With Outlook - Newser
Using Python tools to backtest Coya Therapeutics Inc. strategiesReal-Time AI Generated Market Forecast - Newser
Sector ETF performance correlation with Coya Therapeutics Inc.Trading Watchlist with Real Time Filters - Newser
Tools to monitor Coya Therapeutics Inc. recovery probabilityConservative Equity Setup with Signal Analysis - Newser
Published on: 2025-08-11 07:24:51 - Newser
Understanding Coya Therapeutics Inc.’s price movementConservative Asset Allocation Risk Analysis - Newser
Intrinsic Value of Coya Therapeutics Inc. Stock: Is It Undervalued or OvervaluedAI Volatility Forecast and Risk Monitor - Newser
Coya Therapeutics COYA Q2 2025 Earnings Preview Upside Potential on Promising Product Pipeline - AInvest
How Coya Therapeutics Inc. stock performs during market volatilityTrade Plan With Low Risk High Return - Newser
What drives Coya Therapeutics Inc. stock priceLightning-fast capital gains - Jammu Links News
Does Coya Therapeutics Inc. stock perform well during market downturnsTrack top-performing stocks in real-time - Jammu Links News
How does Coya Therapeutics Inc. generate profit in a changing economyFree Trend-Following Techniques - Jammu Links News
Coya Therapeutics, Inc. (COYA) Surges 10.7%: Is This an Indication of Further Gains? - MSN
Is it the right time to buy Coya Therapeutics Inc. stockGet daily updates on top-performing stocks - Jammu Links News
How many analysts rate Coya Therapeutics Inc. as a “Buy”Explosive earnings growth - Jammu Links News
How strong is Coya Therapeutics Inc. company’s balance sheetUnlock powerful portfolio optimization tools - Jammu Links News
What catalysts could drive Coya Therapeutics Inc. stock higher in 2025Overwhelming financial success - Jammu Links News
What institutional investors are buying Coya Therapeutics Inc. stockAchieve breakthrough results with expert guidance - Jammu Links News
Is Coya Therapeutics Inc. a growth stock or a value stockTremendous growth opportunities - Jammu Links News
What are the technical indicators suggesting about Coya Therapeutics Inc.Get insider insights into market trends - Jammu Links News
What are Coya Therapeutics Inc. company’s key revenue driversCapitalize on emerging trends for profits - Jammu Links News
Should you wait for a breakout in Coya Therapeutics Inc.Free Top Gaining Picks With Entry Signals - Newser
How to manage a losing position in Coya Therapeutics Inc.Intraday Strategy with Real Time Monitoring - Newser
Applying Wyckoff theory to Coya Therapeutics Inc. stockFree AI Screening for Swing Trade Picks - Newser
Is Coya Therapeutics Inc. stock overvalued or undervaluedTop Growth Forecasts Backed By Experts - Jammu Links News
Coya Therapeutics Inc (COYA) 財務データ
収益
当期純利益
現金流量
EPS
Coya Therapeutics Inc (COYA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| SNYDER DAVID S | Chief Financial Officer |
Nov 14 '24 |
Buy |
7.19 |
1,800 |
12,934 |
8,800 |
| Swaminathan Arun | Chief Executive Officer |
Nov 13 '24 |
Buy |
7.36 |
5,000 |
36,797 |
10,000 |
| Grossman Fred | Chief Medical Officer |
Nov 11 '24 |
Buy |
7.37 |
2,710 |
19,973 |
2,710 |
| Swaminathan Arun | Chief Executive Officer |
Nov 11 '24 |
Buy |
7.34 |
5,000 |
36,689 |
5,000 |
0.94%
1.72%
大文字化:
|
ボリューム (24 時間):